Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on molecules ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...

Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...

Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and Exercise, a recent study from the ...

Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

A new study suggests that this side effect of drugs like Ozempic may relieve men of the surprising ailment that affects ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...

Combining ASC47 with semaglutide, the new therapy aims to reshape obesity treatment with targeted, once-monthly injections.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...